BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19
Current monoclonal antibody therapies less effective against emerging COVID-19 variants BiondVax is developing an inhaled nanosized antibody (NanoAb) therapy for…